188 related articles for article (PubMed ID: 31897119)
1. High expression of fibronectin 1 indicates poor prognosis in gastric cancer.
Sun Y; Zhao C; Ye Y; Wang Z; He Y; Li Y; Mao H
Oncol Lett; 2020 Jan; 19(1):93-102. PubMed ID: 31897119
[TBL] [Abstract][Full Text] [Related]
2. High FN1 expression correlates with gastric cancer progression.
Li J; Chen C; Chen B; Guo T
Pathol Res Pract; 2022 Nov; 239():154179. PubMed ID: 36274380
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells.
Zhang H; Sun Z; Li Y; Fan D; Jiang H
Biomed Pharmacother; 2017 Apr; 88():285-292. PubMed ID: 28113080
[TBL] [Abstract][Full Text] [Related]
4. LUM Expression and Its Prognostic Significance in Gastric Cancer.
Chen X; Li X; Hu X; Jiang F; Shen Y; Xu R; Wu L; Wei P; Shen X
Front Oncol; 2020; 10():605. PubMed ID: 32500021
[No Abstract] [Full Text] [Related]
5. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
He XY; Zhao J; Chen ZQ; Jin R; Liu CY
Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
[TBL] [Abstract][Full Text] [Related]
6. FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer.
Zhang XX; Luo JH; Wu LQ
Front Genet; 2022; 13():913659. PubMed ID: 36035176
[No Abstract] [Full Text] [Related]
7. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
8. FN1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers.
Wang H; Zhang J; Li H; Yu H; Chen S; Liu S; Zhang C; He Y
Front Oncol; 2022; 12():918719. PubMed ID: 36081567
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
Liang L; Zhao K; Zhu JH; Chen G; Qin XG; Chen JQ
Oncol Rep; 2019 Aug; 42(2):615-628. PubMed ID: 31233188
[TBL] [Abstract][Full Text] [Related]
10. Vestigial like family member 3 is a novel prognostic biomarker for gastric cancer.
Zhang LH; Wang Z; Li LH; Liu YK; Jin LF; Qi XW; Zhang C; Wang T; Hua D
World J Clin Cases; 2019 Aug; 7(15):1954-1963. PubMed ID: 31423427
[TBL] [Abstract][Full Text] [Related]
11. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog Interacting Protein 1 is a Prognostic Marker and Suppresses Cell Metastasis in Gastric Cancer.
Sun H; Ni SJ; Ye M; Weng W; Zhang Q; Zhang M; Tan C; Wang L; Huang D; Du X; Xu M; Sheng W
J Cancer; 2018; 9(24):4642-4649. PubMed ID: 30588248
[No Abstract] [Full Text] [Related]
13. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.
Huang C; Zhao J; Luo C; Zhu Z
Front Med (Lausanne); 2020; 7():320. PubMed ID: 32733904
[No Abstract] [Full Text] [Related]
15. Upregulation of FGD6 Predicts Poor Prognosis in Gastric Cancer.
Zeng J; Li M; Shi H; Guo J
Front Med (Lausanne); 2021; 8():672595. PubMed ID: 34291059
[No Abstract] [Full Text] [Related]
16. Increased expression of methionine sulfoxide reductases B3 is associated with poor prognosis in gastric cancer.
Ma X; Wang J; Zhao M; Huang H; Wu J
Oncol Lett; 2019 Jul; 18(1):465-471. PubMed ID: 31289518
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of histone modification-associated genes on differential gene expression and prognosis in gastric cancer.
Meng X; Zhao Y; Liu J; Wang L; Dong Z; Zhang T; Gu X; Zheng Z
Exp Ther Med; 2019 Sep; 18(3):2219-2230. PubMed ID: 31452712
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
Tian S; Zhan N; Li R; Dong W
Med Sci Monit; 2019 Apr; 25():3115-3126. PubMed ID: 31028714
[TBL] [Abstract][Full Text] [Related]
19. HOXA13 promotes gastric cancer progression partially via the FN1-mediated FAK/Src axis.
Qin Z; Zhou C
Exp Hematol Oncol; 2022 Feb; 11(1):7. PubMed ID: 35197128
[TBL] [Abstract][Full Text] [Related]
20. Low expression of RecQ-like helicase 5 is associated with poor prognosis in patients with gastric cancer.
Lin Y; Wang H; Wang X; Li M; Chen H; Peng J
Oncol Lett; 2020 Jan; 19(1):985-991. PubMed ID: 31897211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
